Submit Deal

DAIICHI SANKYO COMPANY LIMITED

Deals Overview

Total Deals5

Valued Deals2

Total Value£ 5.41 B

Avg. Deal Size£ 2.70 B

Market Context

Senior Management

George Nakayama
Chairman and CEO
Joji Nakayama
CEO
Ken Keller
President and CEO

Senior Management

George Nakayama
Chairman and CEO
Joji Nakayama
CEO
Ken Keller
President and CEO

Sort

16 Apr 2015|India|Pharmaceuticals

Target: SUN PHARMACEUTICAL INDUSTRIES LTD

Bidder: DAIICHI SANKYO COMPANY LIMITED

1 Service Providers

1 Bidder

2 Dealmakers

2 Bidder

n/a

Value

28 Mar 2019|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (TRASTUZUMAB DERUXTECAN)

Bidder: ASTRAZENECA PLC

3 Service Providers

2 Bidder | 1 Vendor

11 Dealmakers

5 Bidder | 6 Vendor

£ 5.26 B

Value

01 Apr 2020|France|Pharmaceuticals

Target: DAIICHI SANKYO ALTKIRCH SARL

Bidder: AMERICAN REGENT INC

2 Service Providers

1 Bidder | 1 Vendor

3 Dealmakers

2 Bidder | 1 Vendor

n/a

Value

18 Jan 2022|Japan|Pharmaceuticals

Target: DAIICHI SANKYO (EIGHT BRANDED COMMERCIAL PRODUCTS)

Bidder: COSETTE PHARMACEUTICALS

5 Service Providers

3 Bidder | 2 Vendor

5 Dealmakers

4 Bidder | 1 Vendor

n/a

Value

15 May 2023|Japan|Pharmaceuticals

Target: DAIICHI SANKYO ESPHA CO

Bidder: QOL HOLDINGS

1 Service Providers

1 Bidder

£ 147 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy